Equillium begins Phase III acute graft-versus-host disease therapy trial
Equillium has commenced the Phase III EQUATOR clinical trial of itolizumab to treat acute graft-versus-host disease (aGVHD) patients.
Source: clinicaltrialsarena.com
Page 16 - Key Challenges News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Key Challenges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Key Challenges Today - Breaking & Trending Today
Ukraine: Ex-FDAer calls for agency to stop Russian regulatory reviews
"I think it’s a terrible idea if the FDA would keep processing Russia entities’ pitches to enter the US market.”
Source: clinicaltrialsarena.com
Maze Therapeutics initiates dosing in Phase I Pompe disease therapy trial
Maze has commenced participant dosing in its Phase I clinical trial of oral glycogen synthase (GYS1) inhibitor, MZE001, to treat Pompe diseas
Source: clinicaltrialsarena.com
Pardes reports interim data from Phase I trial of oral Covid-19 antiviral
Pardes Biosciences has reported interim results from the Phase I trial of its oral antiviral drug, PBI-0451, in healthy adult subjects.
Source: clinicaltrialsarena.com
IGM Biosciences progresses Covid-19 antibody to two clinical trials
IGM Biosciences has announced the progression of its antibody, IGM-6268, into two clinical trials to treat and prevent Covid-19.
Source: clinicaltrialsarena.com